Cargando…
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
The cholesterol reducing drugs, statins, exhibit anti-tumor effects against cancer stem cells and various cancer cell lines, exert potent additivity or synergy with existing chemotherapeutics in animal models of cancer and may reduce cancer incidence and cancer related mortality in humans. However,...
Autores principales: | Warita, Katsuhiko, Warita, Tomoko, Beckwitt, Colin H., Schurdak, Mark E., Vazquez, Alexei, Wells, Alan, Oltvai, Zoltán N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274516/ https://www.ncbi.nlm.nih.gov/pubmed/25534349 http://dx.doi.org/10.1038/srep07593 |
Ejemplares similares
-
Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics
por: Ishikawa, Takuro, et al.
Publicado: (2018) -
Expression of housekeeping genes varies depending on mevalonate pathway inhibition in cancer cells
por: Irie, Nanami, et al.
Publicado: (2023) -
Carbon catabolite repression correlates with the maintenance of near invariant molecular crowding in proliferating E. coli cells
por: Zhou, Yi, et al.
Publicado: (2013) -
Statins attenuate outgrowth of breast cancer metastases
por: Beckwitt, Colin H., et al.
Publicado: (2018) -
Concomitant attenuation of HMGCR expression and activity enhances the growth inhibitory effect of atorvastatin on TGF-β-treated epithelial cancer cells
por: Warita, Katsuhiko, et al.
Publicado: (2021)